Reproducible cancer biomarker discovery in SELDI-TOF MS using different pre-processing algorithms

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Zou, Jinfeng ^a   Hong, Guini ^a   Guo, Xinwu ^b   Zhang, Lin ^a   Yao, Chen ^a   Wang, Jing ^a   Guo, Zheng ^a,b  

^a UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ALGORITHM; ARTICLE; BREAST CANCER; CONTROLLED STUDY; HUMAN; MASS SPECTROMETRY; NEOPLASM; PROSTATE CANCER; REPRODUCIBILITY; SIGNAL NOISE RATIO; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; BREAST TUMOR; FEMALE; MALE; METABOLISM; METHODOLOGY; PROSTATE TUMOR; SAMPLE SIZE; STATISTICAL MODEL;

ALGORITHMS; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 80054090735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026294     Document Type: Article

References (61)

1. Aebersold R, Mann M, (2003) Mass spectrometry-based proteomics. Nature 422: 198-207.
2. Hanash SM, Pitteri SJ, Faca VM, (2008) Mining the plasma proteome for cancer biomarkers. Nature 452: 571-579.
3. Sanders ME, Dias EC, Xu BJ, Mobley JA, Billheimer D, et al. (2008) Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS. J Proteome Res 7: 1500-1507.
4. Cho WC, (2006) Research progress in SELDI-TOF MS and its clinical applications. Sheng Wu Gong Cheng Xue Bao 22: 871-876.
5. Ein-Dor L, Kela I, Getz G, Givol D, Domany E, (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21: 171-178.
6. Zhang M, Yao C, Guo Z, Zou J, Zhang L, et al. (2008) Apparently low reproducibility of true differential expression discoveries in microarray studies. Bioinformatics 24: 2057-2063.
7. Callesen AK, Vach W, Jorgensen PE, Cold S, Mogensen O, et al. (2008) Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review. J Proteome Res 7: 1395-1402.
8. Diamandis EP, (2004) Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 96: 353-356.
9. De Bock M, de Seny D, Meuwis MA, Chapelle JP, Louis E, et al. (2010) Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol 2010: 906082.
10. Hogan JM, Higdon R, Kolker E, (2006) Experimental standards for high-throughput proteomics. OMICS 10: 152-157.
11. Poon TC, (2007) Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics 4: 51-65.
12. Caffrey RE, (2010) A review of experimental design best practices for proteomics based biomarker discovery: focus on SELDI-TOF. Methods Mol Biol 641: 167-183.
13. Cho WC, (2007) Proteomics technologies and challenges. Genomics Proteomics Bioinformatics 5: 77-85.
14. Kristina G, Radomir P, Eva B, Lenka D, Radek L, et al. (2009) When one chip is not enough: augmenting the validity of SELDI-TOF proteomic profiles of clinical specimens. Lab Chip 9: 1014-1017.
15. Timms JF, Arslan-Low E, Gentry-Maharaj A, Luo Z, T'Jampens D, et al. (2007) Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. Clin Chem 53: 645-656.
16. Baggerly KA, Morris JS, Coombes KR, (2004) Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20: 777-785.
17. Cruz-Marcelo A, Guerra R, Vannucci M, Li Y, Lau CC, et al. (2008) Comparison of algorithms for pre-processing of SELDI-TOF mass spectrometry data. Bioinformatics 24: 2129-2136.
18. Emanuele VA II, Gurbaxani BM, (2009) Benchmarking currently available SELDI-TOF MS preprocessing techniques. Proteomics 9: 1754-1762.
19. Meuleman W, Engwegen JY, Gast MC, Beijnen JH, Reinders MJ, et al. (2008) Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry data. BMC Bioinformatics 9: 88.
20. Du P, Kibbe WA, Lin SM, (2006) Improved peak detection in mass spectrum by incorporating continuous wavelet transform-based pattern matching. Bioinformatics 22: 2059-2065.
21. Coombes KR, Baggerly KA, Morris JS, (2007) Pre-Processing Mass Spectrometry Data Fundamentals of Data Mining in Genomics and Proteomics Springer US.
22. Ransohoff DF, (2005) Lessons from controversy: ovarian cancer screening and serum proteomics. J Natl Cancer Inst 97: 315-319.
23. Shi L, Jones WD, Jensen RV, Harris SC, Perkins RG, et al. (2008) The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics 9 (Suppl 9): S10.
24. Frobel J, Hartwig S, Passlack W, Eckel J, Haas R, et al. (2010) ProteoMiner and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum. Arch Physiol Biochem 116: 174-180.
25. Wong JW, Cagney G, Cartwright HM, (2005) SpecAlign-processing and alignment of mass spectra datasets. Bioinformatics 21: 2088-2090.
26. Ein-Dor L, Zuk O, Domany E, (2006) Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci U S A 103: 5923-5928.
27. Lee ML, Whitmore GA, (2002) Power and sample size for DNA microarray studies. Stat Med 21: 3543-3570.
28. Pawitan Y, Michiels S, Koscielny S, Gusnanto A, Ploner A, (2005) False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics 21: 3017-3024.
29. Truntzer C, Maucort-Boulch D, Roy P, (2008) Comparative optimism in models involving both classical clinical and gene expression information. BMC Bioinformatics 9: 434.
30. Sun L, Craiu RV, Paterson AD, Bull SB, (2006) Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies. Genet Epidemiol 30: 519-530.
31. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, et al. (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62: 3609-3614.
32. Pusztai L, Gregory BW, Baggerly KA, Peng B, Koomen J, et al. (2004) Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer 100: 1814-1822.
33. Li X, Gentleman R, Lu X, Shi Q, Iglehart JD, et al. (2005) SELDI-TOF Mass Spectrometry Protein Data Bioinformatics and Computational Biology Solutions Using R and Bioconductor Ch 6, Springer, New York pp. 91-109.
34. Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL Jr, et al. (2003) A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics 4: 449-463.
35. Li J, Zhao J, Yu X, Lange J, Kuerer H, et al. (2005) Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res 11: 8312-8320.
36. Mathelin C, Cromer A, Wendling C, Tomasetto C, Rio MC, (2006) Serum biomarkers for detection of breast cancers: A prospective study. Breast Cancer Res Treat 96: 83-90.
37. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B Methodological 57: 289-300.
38. Zhang M, Zhang L, Zou J, Yao C, Xiao H, et al. (2009) Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes. Bioinformatics.
39. Carvajal-Rodriguez A, de Una-Alvarez J, Rolan-Alvarez E, (2009) A new multitest correction (SGoF) that increases its statistical power when increasing the number of tests. BMC Bioinformatics 10: 209.
40. Carvalho PC, Fischer JS, Chen EI, Yates JR, III, Barbosa VC, (2008) PatternLab for proteomics: a tool for differential shotgun proteomics. BMC Bioinformatics 9: 316.
41. MacQueen J, (1967) Some methods for classification and analysis of multivariate observations. Fifth Berkeley Symposium on Mathematical Statistics and Probability. Statistical Laboratory of the University of California Berkeley University of California Press pp. 281-297.
42. Rousseeuw PJ, (1987) Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math 20: 53-65.
43. Bell AW, Deutsch EW, Au CE, Kearney RE, Beavis R, et al. (2009) A HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nat Methods 6: 423-430.
44. Fortin T, Salvador A, Charrier JP, Lenz C, Lacoux X, et al. (2009) Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol Cell Proteomics 8: 1006-1015.
45. Esteva FJ, Cheli CD, Fritsche H, Fornier M, Slamon D, et al. (2005) Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies. Breast Cancer Res 7: R436-443.
46. Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, et al. (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28: 595-599.
47. Song HJ, Zhang P, Guo XJ, Liao LM, Zhou ZM, et al. (2009) The proteomic analysis of human neonatal umbilical cord serum by mass spectrometry. Acta Pharmacol Sin 30: 1550-1558.
48. Dijkstra M, Jansen RC, (2009) Optimal analysis of complex protein mass spectra. Proteomics 9: 3869-3876.
49. Huang B, Rangrej J, Paterson AD, Sun L, (2007) The multiplicity problem in linkage analysis of gene expression data- the power of differentiating cis- and trans-acting regulators. BMC Proc 1 (Suppl 1): S142.
50. Li C, Li M, Lange EM, Watanabe RM, (2008) Prioritized subset analysis: improving power in genome-wide association studies. Hum Hered 65: 129-141.
51. Wang J, Zhang Y, Shen X, Zhu J, Zhang L, et al. (2011) Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control. Mol Biosyst 7: 1158-1166.
52. Diao L, Clarke CH, Coombes KR, Hamilton SR, Roth J, et al. (2011) Reproducibility of SELDI Spectra Across Time and Laboratories. Cancer Inform 10: 45-64.
53. Sauve AC, Speed TP, (2004) Normalization, baseline correction and alignment of high-throughput mass spectrometry data.; 2004. Proceedings of the Genomic Signal Processing and Statistics workshop.
54. Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, et al. (2009) Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 8: 113-117.
55. Kuzyk MA, Smith D, Yang J, Cross TJ, Jackson AM, et al. (2009) Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 8: 1860-1877.
56. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, et al. (2008) Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 3: e2706.
57. Rocke DM, Ideker T, Troyanskaya O, Quackenbush J, Dopazo J, (2009) Papers on normalization, variable selection, classification or clustering of microarray data. Bioinformatics 25: 701-702.
58. Klebanov L, Jordan C, Yakovlev A, (2006) A new type of stochastic dependence revealed in gene expression data. Stat Appl Genet Mol Biol 5: Article7.
59. Qiu X, Brooks AI, Klebanov L, Yakovlev N, (2005) The effects of normalization on the correlation structure of microarray data. BMC Bioinformatics 6: 120.
60. Gong X, Wu R, Zhang Y, Zhao W, Cheng L, et al. (2010) Extracting consistent knowledge from highly inconsistent cancer gene data sources. BMC Bioinformatics 11: 76.
61. Mead JA, Bianco L, Bessant C, (2009) Recent developments in public proteomic MS repositories and pipelines. Proteomics 9: 861-881.